An NCI-designated Comprehensive Cancer Center, affiliated with the University of Pittsburgh School of Medicine
Research
Please join us in welcoming Michal Nisnboym Ziv, MD, to UPMC Hillman Cancer Center, effective August 25, 2025. Dr. Nisnboym Ziv is Assistant Professor in the Department of Neurology at the University of Pittsburgh and is affiliated with UPMC Magee-Womens…
Please join us in congratulating Dayana Rivadeneira, PhD, in her new role as Assistant Professor in the Department of Immunology at the University of Pittsburgh and UPMC Hillman Cancer Center, effective September 1, 2025. She will develop an independently funded…
We are pleased to announce that Greg M. Delgoffe, PhD, has agreed to serve as Associate Director (AD) for Basic Science at UPMC Hillman Cancer Center, effective September 1, 2025. Dr. Delgoffe is a distinguished and integral part of the…
We are pleased to announce that Carola Neumann, MD, has agreed to serve as the Program Co-Director of the Oncology Graduate Program, effective September 1, 2025. Dr. Neumann is an associate professor of Pharmacology and Chemical Biology and serves as…
We are pleased to announce James Ohr, DO, as Director of the Northwest Pennsylvania Clinical Trials Program for UPMC Hillman Cancer Center, effective August 1, 2025. In this new role, Dr. Ohr will provide leadership for our OHA medical oncology…
Please join us in welcoming Steven B. Chinn, MD, MPH, FACS, to UPMC Hillman Cancer Center, effective July 21, 2025. Dr. Chinn is Associate Professor in the Department of Otolaryngology at the University of Pittsburgh and will clinically focus on…
A $1.5 million gift will advance sarcoma research at UPMC Hillman Cancer Center through the establishment of the Dr. John A. Shoener Family Endowed Research Fund for Sarcoma. Jacqueline “Jackie” Shoener, inspired by her father’s lifelong commitment to health care…
Please join us in welcoming Curtis McCloskey, PhD, to UPMC Hillman Cancer Center, effective June 2, 2025. Dr. McCloskey is Assistant Professor in the Department of Computational and Systems Biology at the University of Pittsburgh. Dr.McCloskey’s research aims to drive…
Breast cancer is the most commonly diagnosed cancer among women worldwide. Patients diagnosed with breast cancer face the important question of what treatments to choose. While treatment decisions have become more refined over time, they are not yet personalized. Patients…
We are pleased to announce Yana Najjar, MD, as the recipient of this year’s Sy Holzer Endowed Immunotherapy Research Award to advance innovative research in cancer immunotherapy. Dr. Najjar is a research physician at UPMC Hillman Cancer Center, where is…
